Lipocine Director Purchases 123,000 Shares Amid Mixed Clinical News
Director Higuchi John W. bought 123,000 shares of Lipocine Inc. (NASDAQ: LPCN) on April 6, 2026, for $2.05 per share, a transaction totaling $252,149. The purchase brings his direct holdings to 163,797 shares. The transaction coincides with the stock trading close to a 52-week low, and follows Phase 3 trial results for LPCN 1154 that missed the pri…